Treanda (Bendamustine) for Leukemia | MyLeukemiaTeam

Connect with others who understand.

sign up Log in
About MyLeukemiaTeam
Powered By

Treanda, also known by its drug name, bendamustine, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma. Treanda is often prescribed as part of a chemotherapy regimen in combination with rituximab.

Treanda is an anticancer drug used in chemotherapy. Treanda is a member of a class of drugs called alkylating agents. Treanda is believed to work by preventing the production of DNA in cells, blocking cell division.

How do I take it?
Treanda is administered as an intravenous infusion during chemotherapy treatment.

Side effects
The FDA-approved label for Treanda lists common side effects including fatigue, fever, mouth sores, nausea, vomiting, diarrhea, constipation, rash, loss of appetite, weight loss, increased risk for infection, and anemia.

Rare but serious side effects listed for Treanda include severe skin reactions, liver damage, increased risk for other types of cancer, severe allergic reactions, and fetal harm.

For more details about this treatment, visit:

Treanda — Teva

CLL: Chemotherapy and Drug Therapy — Leukemia & Lymphoma Society

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in